{
  "id": 9582845,
  "title": "FDA approves Eli Lilly's once-weekly insulin pen, setting up rivalry with Novo",
  "url": "https://urgent.news/2026/09/24/fda-approves-eli-lillys-once-weekly-insulin-pen-setting-up-rivalry",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-24T16:16:34.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/fda-approves-eli-lillys-once-weekly-insulin-pen-setting-up-rivalry-with-novo/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Eli Lilly’s once-weekly basal insulin shot Onswik has been approved by the FDA for patients with type 2 diabetes. Lilly has touted Onswik as a longer-acting alternative to daily basal insulin injections. It will compete ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Live Mint",
        "title": "Are GLP-1s causing blindness? Novo Nordisk, Eli Lilly face lawsuits in US",
        "url": "https://urgent.news/2026/09/22/are-glp-1s-causing-blindness-novo-nordisk-eli-lilly-face-lawsuits-in",
        "published": "2026-09-22T12:52:57.000Z"
      },
      {
        "outlet": "Quartz",
        "title": "Novo Nordisk and Eli Lilly are being sued over weight loss drugs' link to vision loss",
        "url": "https://urgent.news/2026/09/22/novo-nordisk-and-eli-lilly-are-being-sued-over-weight-loss-drugs-link",
        "published": "2026-09-22T16:50:27.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}